Skip to main content

Advertisement

SpringerLink
Log in

Validation and Quality Control of Protein Microarray-based Analytical Methods

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Protein microarray technology is used mainly in the research laboratory and it is being used to uncover important diagnostic and prognostic markers that may one day emerge as routine clinical laboratory tests. It is important that these methods are subject to control procedures, in order to ensure that data of the highest quality are obtained. If quality is not controlled, the assay may yield erroneous results that would mask or confound meaningful diagnostic or prognostic associations. This chapter surveys the range of strategies designed to assure the analytical quality of protein microarray methods and it also highlights some of the potential pitfalls when moving these arrays into routine clinical practice. With the development of appropriate quality control and assurance measures, we anticipate protein microarray-based assays will be of substantial benefit in the future practice of laboratory medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Schena, M. (Ed.) (1999). DNA microarrays. A Practical Approach. Oxford: Oxford University Press.

    Google Scholar 

  2. Copland, J. A., Davies, P. J., Shipley, G. L., Wood, C. G., Luxon, B. A., & Urban, R. J. (2003). The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside. Recent Progress in Hormone Research, 58, 25–53.

    PubMed  CAS  Google Scholar 

  3. Geschwind, D. H. (2003). DNA microarrays: translation of the genome from laboratory to clinic. Lancet Neurology, 2, 275–282.

    PubMed  CAS  Google Scholar 

  4. Mariadason, J. M., Augenlicht, L. H., & Arango D. (2003). Microarray analysis in the clinical management of cancer. Hematology/Oncology Clinics of North America, 17, 377–387.

    PubMed  Google Scholar 

  5. Pusztai, L., Ayers, M., Stec, J., & Hortobagyi, G. N. (2003). Clinical application of cDNA microarrays in oncology. Oncologist, 8, 252–258.

    PubMed  CAS  Google Scholar 

  6. Sevenet, N., & Cussenot. O. (2003). DNA microarrays in clinical practice: past, present, and future. Clinical and Experimental Medicine, 3, 1–3.

    PubMed  CAS  Google Scholar 

  7. Shaughnessy, J. Jr. (2003). Primer on medical genomics. Part IX: scientific and clinical applications of DNA microarrays–multiple myeloma as a disease model. Mayo Clinic Proceedings, 78, 1098–1109.

    Article  PubMed  CAS  Google Scholar 

  8. Kricka, L. J., & Fortina, P. (2001). Microarray technology and applications: an all-language literature survey including books and patents. Clinical Chemistry, 47, 1479–1482.

    PubMed  CAS  Google Scholar 

  9. Albala, J. S. (2001). Array-based proteomics: the latest chip challenge. Expert Review of Molecular Diagnostics, 1, 145–152.

    PubMed  CAS  Google Scholar 

  10. Cutler, P. (2003). Protein arrays: the current state-of-the-art. Proteomics, 3, 3–18.

    PubMed  CAS  Google Scholar 

  11. Schena, M. (ed.) (2004). Protein Microarrays Jones & Bartlett. Boston. Eickhoff, H., Konthur, Z., Lueking, A., Lehrach, H., Walter, G., Nordhoff, E., Nyarsik, L., & Bussow, K. (2002). Protein array technology: the tool to bridge genomics and proteomics. Advances in Biochemical Engineering/Biotechnology, 77, 103–112.

  12. Liotta, L. A., Espina, V., Mehta, A. I., Calvert, V., Rosenblatt, K., Geho, D., Munson, P. J., Young, L., Wulfkuhle, & Petricoin, E. F. III. (2003). Protein microarrays: Meeting analytical challenges for clinical applications. Cancer Cell, 3, 317–325.

  13. MacBeath, G. (2002). Protein microarrays and proteomics. Nature Genetics, 32(Suppl), 526–532.

    PubMed  CAS  Google Scholar 

  14. Schweitzer, B., & Kingsmore, S. F. (2002). Measuring proteins on microarrays. Current Opinion in Biotechnology, 13, 14–19.

    PubMed  CAS  Google Scholar 

  15. Templin, M. F., Stoll, D., Schrenk, M., Traub, P. C., Vohringer, C. F., & Joos T.O. (2002). Protein microarray technology. Drug Discovery Today, 7, 815–822.

    PubMed  CAS  Google Scholar 

  16. Zhu, H., & Snyder, M. (2003). Protein chip technology. Current Opinion in Chemical Biology, 7, 55–63.

    PubMed  CAS  Google Scholar 

  17. Kricka, L. J., Joos, T., & Fortina, P. (2003). Protein microarrays: a literature survey. Clinical Chemistry, 49, 2109.

    PubMed  CAS  Google Scholar 

  18. Petricoin, E. F., & Liotta, L. A. (2003). Clinical applications of proteomics. The Journal of Nutrition, 133(Suppl), 2476S–2484S.

    PubMed  CAS  Google Scholar 

  19. Drmanac, R., Drmanac, S., Chui, G., Diaz, R., Hou, A., Jin, H., Jin, P., Kwon, S., Lacy, S., Moeur, B., Shafto, J., Swanson, D., Ukrainczyk, T., Xu, C., & Little, D. (2002). Sequencing by hybridization (SBH): advantages, achievements, and opportunities. Advances in Biochemical Engineering/Biotechnology, 77, 75–101.

    Article  PubMed  CAS  Google Scholar 

  20. Prix, L., Uciechowski, P., Bockmann, B., Giesing, M., & Schuetz, A. J. (2002). Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool. Clinical Chemistry, 48, 428–435.

    PubMed  CAS  Google Scholar 

  21. Schaefer, K. L., Wai, D., Poremba, C., Diallo, R., Boecker, W., & Dockhorn-Dworniczak, B. (2002). Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology. Medical and Pediatric Oncology, 38, 247–53.

    PubMed  Google Scholar 

  22. Warrington, J. A., Shah, N. A., Chen, X., Janis, M., Liu, C., Kondapalli, S., Reyes, V., Savage, M. P., Zhang, Z., Watts, R., DeGuzman, M., Berno A., Snyder, J., & Baid, J. (2002). New developments in high-throughput resequencing and variation detection using high density microarrays. Human Mutation, 19, 402–409.

    PubMed  CAS  Google Scholar 

  23. Huang, R. P., Huang, R., Fan, Y., & Lin, Y. (2001). Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Analytical Biochemistry, 294, 55–62.

    PubMed  CAS  Google Scholar 

  24. Lin, Y., Huang, R., Cao, X., Wang, S. M., Shi, Q., & Huang, R. P. (2003). Detection of multiple cytokines by protein arrays from cell lysate and tissue lysate. Clinical Chemistry and Laboratory Medicine, 41, 139–145.

    PubMed  CAS  Google Scholar 

  25. Fall, B. I., Eberlein-Konig, B., Behrendt, H., Niessner, R., Ring, J., & Weller, M.G. (2003). Microarrays for the screening of allergen-specific IgE in human serum. Analytical Biochemistry, 75, 556–562.

    CAS  Google Scholar 

  26. Harwanegg, C., Laffer, S., Hiller, R., Mueller, M. W., Kraft, D., Spitzauer, S., & Valenta, R. (2003). Microarrayed recombinant allergens for diagnosis of allergy. Clinical and Experimental Allergy, 33, 7–13.

    PubMed  CAS  Google Scholar 

  27. Jahn-Schmid, B., Harwanegg, C., Hiller, R., Bohle, B., Ebner, C., Scheiner, O., & Mueller, M. W. (2003). Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clinical and Experimental Allergy, 33, 1443–1449.

    PubMed  CAS  Google Scholar 

  28. Kim, T. E., Park, S. W., Cho, N. Y., Choi, S. Y., Yong, T. S., Nahm, B. H., Lee, S., & Noh, G. (2002). Quantitative measurement of serum allergen-specific IgE on protein chip. Experimental & Molecular Medicine, 34, 152–158.

    CAS  Google Scholar 

  29. Lipshutz, R. J., Fodor, S. P., Gingeras, T. R., & Lockhart, D. J. (1999). High density synthetic oligonucleotide arrays. Nature Genetics, 21(Suppl), 20–24.

    PubMed  CAS  Google Scholar 

  30. Southern, E. M. (2001). DNA microarrays. History and overview. Methods in Molecular Biology, 170, 1–15.

    PubMed  CAS  Google Scholar 

  31. Martins, T. B. (2002). Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clinical and Diagnostic Laboratory Immunology, 9, 41–45.

    PubMed  Google Scholar 

  32. Ekins, R. P. (1998). Ligand assays: from electrophoresis to miniaturized microarrays. Clinical Chemistry, 44, 2015–30.

    PubMed  CAS  Google Scholar 

  33. Chou, W. H., Yan, F. X., Robbins-Weilert, D. K., Ryder, T. B., Liu, W. W., Perbost, C., Fairchild, M., De Leon, J., Koch, W. H., & Wedlund, P. J. (2003). Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships. Clinical Chemistry, 49, 542–551.

    PubMed  CAS  Google Scholar 

  34. Wilson, J. W., Bean, P., Robins, T., Graziano, F., & Persing, D. H. (2000). Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay. Journal of Clinical Microbiology, 38, 3022–3028.

    PubMed  CAS  Google Scholar 

  35. Salvado, C. S., Trounson, A. O., & Cram, D. S. (2004). Towards preimplantation diagnosis of cystic fibrosis using microarrays. Reproductive Biomedicine, 8, 107–114.

    Article  CAS  Google Scholar 

  36. Ahrendt, S. A., Hu, Y., Buta, M., McDermott, M. P., Benoit, N., Yang, S. C., Wu, L., & Sidransky, D. (2003). p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. Journal of the National Cancer Institute, 95, 961–970.

    Article  PubMed  CAS  Google Scholar 

  37. Warrington, J. A., Shah, N. A., Chen, X., Janis, M., Liu, C., Kondapalli, S., Reyes, V., Savage, M. P., Zhang, Z., Watts, R., DeGuzman, M., Berno, A., Snyder, J., & Baid, J. (2002). New developments in high-throughput resequencing and variation detection using high density microarrays. Human Mutation, 19, 402–409.

    PubMed  CAS  Google Scholar 

  38. Hacia, J. G. (1999). Resequencing and mutational analysis using oligonucleotide microarrays. Nature Genetics, 21(Suppl), 42–47.

    PubMed  CAS  Google Scholar 

  39. Onwuazor, O. N., Wen, X. Y., Wang, D. Y., Zhuang, L., Masih-Khan, E., Claudio, J., Barlogie, B., Shaughnessy, J. D. Jr, & Stewart, A. K. (2003). Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients. Blood, 102, 772–773.

    PubMed  CAS  Google Scholar 

  40. Kling, J. (2003). Roche’s microarray tests. US FDA’s diagnostic policy. Nature Biotechnology, 21, 959–960.

    PubMed  CAS  Google Scholar 

  41. Petricoin, E. F. 3rd, Hackett, J. L., Lesko, L. J., Puri, R. K., Gutman, S. I., Chumakov, K., Woodcock, J., Feigal, D. W. Jr., Zoon, K. C., & Sistare, F. D. (2002). Medical applications of microarray technologies: a regulatory science perspective. Nature Genetics, 32(Suppl.), 474–479.

    PubMed  CAS  Google Scholar 

  42. Brown, C. R., Higgins, K. W., Frazer. K., Schoelz, L. K., Dyminski, J. W., Marinkovich, V. A., Miller, S. P., & Burd, J. F. (1985). Simultaneous determination of total IgE and allergen-specific IgE in serum by the MAST chemiluminescent assay system. Clinical Chemistry, 31, 1500–1505.

    PubMed  CAS  Google Scholar 

  43. Price, C.P, Hicks, J. M. (eds) (1999). Point-of-Care Testing. AACC Press, Washington.

    Google Scholar 

  44. Koch, D. O., & Peters, T. Jr. (1999). Selection and evaluation methods. In: Burtis, C. A., Ashwood, E. R. (eds.), Tietz textbook of clinical chemistry, 3rd edn. (pp. 320–335). Philadelphia: WB Saunders.

    Google Scholar 

  45. Carey, R. N., & Garber, C. C. (1989). Evaluation of methods, In: Kaplan, L. A., Pesce, A. J. (eds.), Clinical Chemistry. Theory, Practice and Correlation 2nd edn. (pp. 290–310). St. Louis: CV Mosby.

    Google Scholar 

  46. Hoeltge, G. A., & Duckworth, J. K. (1987). Review of proficiency testing performance of laboratories accredited by the College of American Pathologists. Archives of Pathology & Laboratory Medicine, 111, 1011–1014.

    CAS  Google Scholar 

  47. Whitehead, T. P., & Woodford, F. P. (1981). External quality assessment of clinical laboratories in the United Kingdom. Journal of Clinical Pathology, 34, 947–957.

    PubMed  CAS  Google Scholar 

  48. Mezzasoma, L., Bacarese-Hamilton, T., Di Cristina, M., Rossi, R., Bistoni, F., & Crisanti, A. (2002). Antigen microarrays for serodiagnosis of infectious diseases. Clinical Chemistry, 48, 121–130.

    PubMed  CAS  Google Scholar 

  49. Angenendt, P., Glokler, J., Murphy, D., Lehrach, H., & Cahill, D. J. (2002). Toward optimized antibody microarrays: a comparison of current microarray support materials. Analytical Biochemistry, 309, 253–260.

    PubMed  CAS  Google Scholar 

  50. Peluso, P., Wilson, D. S., Do, D., Tran, H., Venkatasubbaiah, M., Quincy, D., Heidecker, B., Poindexter, K., Tolani, N., Phelan, M., Witte, K., Jung, L. S., Wagner, P., & Nock, S. (2003). Optimizing antibody immobilization strategies for the construction of protein microarrays. Analytical Biochemistry, 312, 113–124.

    PubMed  CAS  Google Scholar 

  51. Belov, L., Huang, P, Barber, N., Mulligan, S. P., & Christopherson, R. I. (2003). Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics, 3, 2146–2154.

    Google Scholar 

  52. Kiyonaka, S., Sada, K., Yoshimura, I., Shinkai, S., Kato, N., & Hamachi, I. (2004). Semi-wet peptide/protein array using supramolecular hydrogel. Nature materials, 3, 58–64.

    PubMed  CAS  Google Scholar 

  53. Espina, V., Mehta, A. I., Winters, M. E., Calvert, V., Wulfkuhle, J., Petricoin III E. F., & Liotta, L. A. (2003). Protein microarrays: Molecular profiling technologies for clinical specimens. Proteomics, 3, 2091–2100.

    PubMed  CAS  Google Scholar 

  54. Grubb, R. L., Calvert, V. S., Wulkuhle, J. D., Paweletz, C. P., Linehan, W. M., Phillips, J. L., Chuaqui, R., Valasco, A., Gillespie, J., Emmert-Buck, M., Liotta, L. A., & Petricoin, E. F. (2003). Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics, 3, 2142–2146.

    PubMed  CAS  Google Scholar 

  55. Coleman, M. A., Miller, K. A., Beernink, P. T., Yoshikawa, D. M., Albala, J. S. (2003). Identification of chromatin-related protein interactions using protein microarrays. Proteomics, 3, 2101–2107.

    PubMed  CAS  Google Scholar 

  56. Kingsmore, S. F., & Patel, D.D. (2003). Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. Current Opinion in Biotechnology, 14, 74–81.

    PubMed  CAS  Google Scholar 

  57. MacBeath, G., & Schreiber, S. L. (2000). Printing proteins as microarrays for high-throughput function determination. Science, 289, 1760–1763.

    PubMed  CAS  Google Scholar 

  58. Neuman de Vegvar, H. E., Amara, R. R., Steinman, L., Utz, P. J., Robinson, H. L., & Robinson, W. H. (2003). Microarray profiling of antibody responses against simian-human immunodeficiency virus: postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen. Journal of Virology, 77, 11125–11138.

    Google Scholar 

  59. Sreekumar, A., Nyati, M. K., Varambally, S., Barrette, T. R., Ghosh, D., Lawrence, T. S., & Chinnaiyan A.M. (2001). Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Research, 61, 7585–7593.

    PubMed  CAS  Google Scholar 

  60. Delehanty, JB., & Ligler, FS. (2002). A microarray immunoassay for simultaneous detection of proteins and bacteria. Analytical Chemistry, 74, 5681–5687.

    PubMed  CAS  Google Scholar 

  61. Bouwman, K., Qiu, J., Zhou, H., Schotanus, M., Mangold, L. A., Vogt, R., Erlandson, E., Trenkle, J., Partin, A. W., Misek, D., Omenn, G. S., Haab, B. B., Samir, & Hanash, S. (2003). Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics, 3, 2200–2207.

    PubMed  CAS  Google Scholar 

  62. Nam, M. J., Madoz-Gurpide, KJ., Wang, H., Lescure, P., Schmalbach, C. E., Zhao, R., Misek, D. E., Kuick, R., Brenner, D. E., Samir, M., & Hanash, S. M. (2003). Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics, 3, 2108–2115.

    PubMed  CAS  Google Scholar 

  63. de Jager W., te Velthuis, H., Prakken, B. J., Kuis, W., & Rijkers G.T. (2003). Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clinical and Diagnostic Laboratory Immunology, 10, 133–139.

    PubMed  Google Scholar 

  64. Copeland, S., Siddiqui, J., & Remick, D. (2004). Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. Journal of Immunological Methods, 284, 99–106.

    PubMed  CAS  Google Scholar 

  65. Wiltshire, S., O’Malley, S., Lambert, J., Kukanskis, K., Edgar, D., Kingsmore, S. F., & Schweitzer B. (2000). Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clinical Chemistry, 46, 1990–1993.

    PubMed  CAS  Google Scholar 

  66. Belov, L., de la Vega, O., dos Remedios, C. G., Mulligan, S. P., & Christopherson, R. I. (2001). Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Research, 61, 4483–4489.

    PubMed  CAS  Google Scholar 

  67. Ge, H. (2000). UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Research, 28, e3.

    PubMed  CAS  Google Scholar 

  68. Levit-Binnun, N., Lindner, A. B., Zik, O., Eshhar, Z., & Moses, E. (20030 Quantitative detection of protein arrays. Analytical Chemistry, 75, 1436–1441.

    PubMed  CAS  Google Scholar 

  69. Huang, J. X., Mehrens, D., Wiese, R., Lee, S., Tam S.W., Daniel S., Gilmore J., Shi M., & Lashkari, D. (2001). High-throughput genomic and proteomic analysis using microarray technology. Clinical Chemistry, 47, 1912–1916.

    PubMed  CAS  Google Scholar 

  70. Lin, Y., Huang, R., Santanam, N., Liu, Y. G., Parthasarathy, S., & Huang, R. P. (2002). Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Letters, 187, 17–24.

    PubMed  CAS  Google Scholar 

  71. Mullenix, M. C., Wiltshire, S., Shao, W., Kitos, G., & Schweitzer, B. (2001). Allergen-specific IgE detection on microarrays using rolling circle amplification: Correlation with in vitro assays for serum IgE. Clinical Chemistry, 47, 1926 - 1929.

    Google Scholar 

  72. Bacarese-Hamilton, T., Bistoni, F., & Crisanti, A. (2002). Protein microarrays: from serodiagnosis to whole proteome scale analysis of the immune response against pathogenic microorganisms. Biotechniques Suppl., 24–29.

  73. Feng, Y., Ke, X., Ma, R., Chen, Y., Hu, G., & Liu, F. (2004). Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clinical Chemistry, 50, 416–422.

    PubMed  CAS  Google Scholar 

  74. Scorilas, A., Bjartell, A., Lilja, H., Moller, C., & Diamandis, E. P. (2000). Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays. Clinical Chemistry, 46, 1450–455.

    PubMed  CAS  Google Scholar 

  75. Lueking, A., Horn, M., Eickhoff, H., Bussow, K., Lehrach, H., & Walter, G. (1999). Protein microarrays for gene expression and antibody screening. Analytical Biochemistry, 270, 103–111.

    PubMed  CAS  Google Scholar 

  76. Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin, III E. F., & Liotta, L. A. (2001). Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene, 20, 1981–1989.

  77. Carlisle, A. J., Prabhu, V. V., Elkahloun, A., Hudson, J., Trent, J. M., Linehan, W. M., Williams, E. D., Emmert-Buck, M. R., Liotta, L. A., Munson, P. J., & Krizman, D. B. (2000). Development of a Prostate cDNA Microarray and Statistical Gene Expression Analysis Package. Molecular Carcinogenesis, 28, 12–22.

    Google Scholar 

  78. Haab, B. B., Dunham, M. J., & Brown PO. (2001). Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome biology, 2, research0004.1–0004.13.

    Google Scholar 

  79. Grubb, R. L., Calvert, V. S., Wulkuhle, J.D, Paweletz, C. P., Linehan, W. M., Phillips, J. L., Chuaqui, R., Valasco, A., Gillespie, J., Emmert-Buck, M., Liotta, L. A., Petricoin, E. F. (2003). Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics, 3, 2142–2146.

    PubMed  CAS  Google Scholar 

  80. Neuman de Vegvar, H. E., Amara, R.R, Steinman, L., Utz, P. J., Robinson, H. L., & Robinson, W. H. (2003). Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen. J Viron, 7, 11125–11138.

    Google Scholar 

  81. Ekins, R. P., Chu, F., & Biggart, E. (1990). Fluorescence spectroscopy and its application to a new generation of high sensitivity, multi-microspot, multianalyte, immunoassay. Clinica Chimica Acta, 194, 91–114.

    CAS  Google Scholar 

  82. Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A., Coukos, G., Liotta, L. A., Petricoin III, E. F. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics, 3, 2085–2090.

  83. Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., Brown, E. L. (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnology, 14, 1675–1680.

    PubMed  CAS  Google Scholar 

  84. Petricoin, E. F. 3rd, Hackett, J. L., Lesko, L. J., Puri, R. K., Gutman, S.I., Chumakov, K., Woodcock, J., Feigal, D. W. Jr., Zoon, K. C., & Sistare, F. D. (2002). Medical applications of microarray technologies: a regulatory science perspective. Nature Genetics, 32(Suppl), 474–479.

    PubMed  CAS  Google Scholar 

  85. Lee, M. L., Kuo, F. C., Whitmore, G. A., & Sklar, J. (2000). Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proceedings of the National Academy of Sciences of the United States of America, 97, 9834–9839.

    PubMed  CAS  Google Scholar 

  86. Pavlidis, P., Qinghong, L., & Noble, W. S. (2003). The effect of replication on gene expression microarray experiments. Bioinformatics, 19, 1620–1627.

    PubMed  CAS  Google Scholar 

  87. Lipshutz, R. J., Fodor, S. P., Gingeras, T. R., & Lockhart, D. J. (1999). High density synthetic oligonucleotide arrays. 1999. Nature Genetics, 21(Suppl), 20–24.

    PubMed  CAS  Google Scholar 

  88. Cheng Li, C., & Wing Hung Wong, W. H. (2001). Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proceedings of the National Academy of Sciences of the United States of America, 98, 31–36.

    Google Scholar 

  89. Lemon, W. J., Liyanarachchi, S., & You, M. (2003). A high performance test of differential gene expression for oligonucleotide arrays. Genome Biology, 4, R67.

  90. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., Gaasterland, T., Glenisson, P., Holstege, F. C., Kim, I. F., Markowitz, V., Matese, J. C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J., & Vingron, M. (2001). Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genetics, 29, 365–371.

    PubMed  CAS  Google Scholar 

  91. Ball, C. A., Sherlock, G., Parkinson, H., Rocca-Sera, P., Brooksbank, C., Causton, H. C., Cavalieri, D., Gaasterland, T., Hingamp, P., Holstege, F., Ringwald, M., Spellman, P., Stoeckert, C. J., Jr., Stewart, J. E., Taylor, R., Brazma, A., & Quackenbush, J. (2002). Standards for microarray data. Science, 298, 539.

    PubMed  CAS  Google Scholar 

  92. Taylor, C. F., Paton, N. W., Garwood, K.L, Kirby, P. D., Stead, D. A., Yin, Z., Deutsch, E. W., Selway, L., Walker, J., Riba-Garcia, I., Mohammed, S, Deery, M. J., Howard, J. A., Dunkley, T., Aebersold, R., Kell, D. B., Lilley, K. S., Roepstorff P., Yates, J. R. 3rd, Brass, A., Brown, A. J., Cash, P., Gaskell, S. J., Hubbard, S. J., & Oliver S.G. (2003). A systematic approach to modeling, capturing, and disseminating proteomics experimental data. Nature Biotechnology, 21, 247–254.

    PubMed  CAS  Google Scholar 

  93. Orchard, S., Hermjakob, H., Julian, R. K. Jr, Runte, K., Sherman, D., Wojcik, J., Zhu, W., & Apweiler, R. (2004). Common interchange standards for proteomics data: Public availability of tools and schema. Proteomics, 4, 490–491.

    PubMed  CAS  Google Scholar 

  94. Kuo, W. P., Jenssen, T. K., Butte, A. J., Ohno-Machado, L., & Kohane, I. S. (2002). Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics, 18, 405–412.

    PubMed  CAS  Google Scholar 

  95. Barczak, A., Rodriguez, M. W., Hanspers, K., Koth, L. L., Tai, Y. C., Bolstad, B. M., Speed, T. P., & Erle, D. J. (2003). Spotted long oligonucleotide arrays for human gene expression analysis. Genome Research, 13, 1775–1785.

    PubMed  CAS  Google Scholar 

  96. Culhane, A. C., Perrière, G., & Higgins, D. G. (2003). Cross-platform comparison and visualization of gene expression data using co-inertia analysis. BMC Bioinformatics, 4, 59.

    PubMed  Google Scholar 

  97. Johnson, K. F., & Lin, S. M. (2001). Critical assessment of microarray data analysis: the, 2001 challenge. Bioinformatics, 17, 857–858.

    PubMed  CAS  Google Scholar 

  98. The Tumor Analysis Best Practices Working Group. (2004). Expression profiling—best practices for data generation and interpretation in clinical trials. Nature Reviews. Genetics, 5, 229–237.

    Google Scholar 

  99. Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, LM. (2003). A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 100, 9991–9996.

    PubMed  CAS  Google Scholar 

  100. van de Vijver, M. J., He, Y. D., van’t Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., & Bernards, R. (2002). A gene-expression signature as a predictor of survival in breast cancer. The New England Journal of Medicine, 347, 1999–2009.

    PubMed  Google Scholar 

  101. Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003). A molecular signature of metastasis in primary solid tumors. Nature Genetics, 33, 49–54.

    PubMed  CAS  Google Scholar 

  102. Ross, M. E., Zhou, X., Song, G., Shurtleff, S. A., Girtman, K., Williams, W. K., Liu, H. C., Mahfouz, R., Raimondi, S. C., Lenny, N., Patel, A., & Downing, J. R. 2003. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood, 102, 2951–2159.

    PubMed  CAS  Google Scholar 

  103. Sorlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., Borresen-Dale, A. L. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America, 98, 10869–10874.

    PubMed  CAS  Google Scholar 

  104. Hessner, M. J., Wang X., Khan, S., Meyer, L., Schlicht, M., Tackes, J., Datta, M. W., Jacob, H. J., & Ghosh, S. (2003). Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility. Nucleic Acids Research, 31, e60.

    PubMed  Google Scholar 

  105. Boa, Z., Ma, W. L., Hu, Z. Y., Rong, S, Shi, Y. B., & Zheng, W. L. (2002). A method for evaluation of the quality of DNA microarray spots. Journal of Biochemistry and Molecular Biology, 35, 532–535.

    PubMed  Google Scholar 

  106. Shearstone, J. R., Allaire, N. E., Getman, M. E., & Perrin S. (2002). Nondestructive quality control for microarray production. Biotechniques, 32, 1051–1052, 1054, 1056–1057.

    Google Scholar 

  107. Sengupta, R., & Tompa, M. (2001). Quality control in manufacturing oligo arrays: a combinatorial design approach. Pacific Symposium on Biocomputing, 348–359.

  108. Wang, X., Ghosh, S., & Guo, S. W. (2001). Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Research, 29, E75–5.

    PubMed  CAS  Google Scholar 

  109. Johnson, K., & Lin, S. (2003). QA/QC as a pressing need for microarray analysis: meeting report from CAMDA’02. Biotechniques Suppl, 62–63.

  110. Johnson, K. F., & Lin, S. M. (2001). Critical assessment of microarray data analysis: the 2001 challenge. Bioinformatics, 17, 857–858.

    PubMed  CAS  Google Scholar 

  111. Westgard, J. O., Barry, P. L., Hunt, M. R., & Groth, T. (1981). A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chemistry, 27, 493–501.

    CAS  Google Scholar 

  112. Ledue, T. B., Collins, M. F., Ritchie, R. F. (2002). Development of immunoturbidimetric assays for fourteen human serum proteins on the Hitachi 912. Clinical Chemistry and Laboratory Medicine, 40, 520–528.

    PubMed  CAS  Google Scholar 

  113. Tello, F. L., & Hernandez, D. M. (2000). Performance evaluation of nine hormone assays on the Immulite 2000 immunoassay system. Clinical Chemistry and Laboratory Medicine, 38, 1039–1042.

    PubMed  CAS  Google Scholar 

  114. Broussard, L. A., & Hanson, L. (1997). Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira. Clinical Laboratory Science, 10, 83–86.

    PubMed  CAS  Google Scholar 

  115. Thakkar, H., Newman, D. J., Holownia, P., Davey, C. L., Wang, C. C., Lloyd, J., Craig, A. R., & Price, C. P. (1997). Development and validation of a particle-enhanced turbidimetric inhibition assay for urine albumin on the Dade aca analyzer. Clin Chemistry, 43, 109–113.

    CAS  Google Scholar 

  116. Letellier, M., Levesque, A., Daigle, F., & Grant, A. (1996). Performance evaluation of automated immunoassays on the Technicon Immuno 1 system. Clin Chemistry, 42, 1695–1701.

    CAS  Google Scholar 

  117. Sickinger, E., Stieler, M., Kaufman, B., Kapprell, H. P., West, D. Sandridge, A., Devare, S., Schochetman, G., Hunt, J. C., Daghfal, D. AxSYM Clinical Study Group. (2004). Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. Journal of Clinical Microbiology, 42, 21–29.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, 7.103 Founders Pavilion, University of Pennsylvania Medical Center, 3400 Spruce St., Philadelphia, PA, 19104, USA

    Larry J. Kricka & Stephen R. Master

Authors
  1. Larry J. Kricka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen R. Master
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Larry J. Kricka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kricka, L.J., Master, S.R. Validation and Quality Control of Protein Microarray-based Analytical Methods. Mol Biotechnol 38, 19–31 (2008). https://doi.org/10.1007/s12033-007-0066-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-007-0066-5

Keywords

Search

Navigation